Head of Product Cluster, Regulatory Affairs Marketed Products Strategy
Alexion Astra Zeneca Rare Diseases
Mercè Caturla Goñi has over 20 years of pharmaceutical industry experience with Global Regulatory Affairs leading medicines and vaccines clinical trials and drug registration activities in different therapeutic areas (infectious diseases, global public health, dermatology and rare diseases) and markets (Europe, Middle East, Asia, Latin America and Africa). She is a strong and active advocate for regulatory policy and advocacy through proactive engagement with NGOs, Regulatory Agencies or governments. She has held numerous leadership roles in this capacity such as World Health Organization (WHO) Regulatory liaison and International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) African Regulatory Network (ARN) Chair between 2014 -2017. Prior to joining the industry, Mercè held several positions over 12 years in basic research.
Disclosure information not submitted.
International Regulatory Frameworks to Accelerate Orphan Drug Registrations
Wednesday, May 8, 2024
14:00 – 15:00 CEST